Singapore Govt Links With GSK, Takeda, Sanofi In Biopharma Manufacturing Boost

New Consortium Formed

 
• By Lisa Takagi

As Singapore aims for growth in its biopharma manufacturing capability, three key players in the pharmaceutical industry announced plans to join a newly-formed public-private consortium designed to foster innovation in the production of vaccines and biologics.

The three firms has already opened or in construction of new manufacturing sites in Singapore
new project aims to boost Singapore's position as biopharma manufacturing hub • Source: Shutterstock

More from Focus On Asia

More from Scrip